Primary small neuroendocrine carcinoma (SNEC) of the tonsil it’s a rarity. We present the case of a 64 year-old Caucasian male patient referred to our hospital due to a neck mass. A fixed non-tender rock hard supraclavicular right mass and ipsilateral cervical lymphadenopathy was palpable. Biopsy was performed and showed poor differentiated neoplasm with features of SNEC. A fludeoxyglucose positron emission tomography (FDG-PET) scan showed intense uptake in the right tonsil. The patient underwent right tonsillectomy and immunochemistry was positive for characteristic features of small cell neuroendocrine carcinoma. Right tonsil SNEC was diagnosed and the patient was proposed to chemotherapy
Neuroendocrine tumors (NETs) arise from neuroendocrine cells and are mostly observed in the gastroin...
Neuroendocrine tumors are the most common nonsquamous types of laryngeal neoplasms. They are classif...
Extra pulmonary small cell carcinomas are extremely rare, accounting for 0.1-0.4% of all malignancie...
Xing Wang,1,2 Qiming Chen,1 Jian Meng1 1Department of Oromaxillofacial-Head and Neck Surgery, Affil...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Small cell neuroendocrine carcinoma (SNEC) is a rare form of malignancy. It mainly presents as bronc...
Metastasis from a malignant tumor to the palatine tonsils is rare, accounting for only 0.8 % of all ...
In the head and neck mucosa, neuroendocrine carcinomas of the oral cavity is rare. Herein, we presen...
Small cell cancer (SCC) of the tonsil is a rare and aggressive cancer. There are only 10 cases of to...
Small cell neuroendocrine carcinoma rarely appears primarily in the head and neck and exhibits aggre...
Neuroendocrine tumors are very rare tumors that occur most commonly in the gastrointestinal tract. T...
Patients with head and neck cancer have a greater risk of developing second primary malignant neopla...
We report a case of small cell neuroendocrine carcinoma of laryngeal localization. The involvement o...
Sinonasal Neuroendocrine Carcinoma (SNEC) is a very rare malignancy which is difficult to differenti...
Primary neuroendocrine carcinomas of the breast are extremely rare. Neuroendocrine tumors mainly occ...
Neuroendocrine tumors (NETs) arise from neuroendocrine cells and are mostly observed in the gastroin...
Neuroendocrine tumors are the most common nonsquamous types of laryngeal neoplasms. They are classif...
Extra pulmonary small cell carcinomas are extremely rare, accounting for 0.1-0.4% of all malignancie...
Xing Wang,1,2 Qiming Chen,1 Jian Meng1 1Department of Oromaxillofacial-Head and Neck Surgery, Affil...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Small cell neuroendocrine carcinoma (SNEC) is a rare form of malignancy. It mainly presents as bronc...
Metastasis from a malignant tumor to the palatine tonsils is rare, accounting for only 0.8 % of all ...
In the head and neck mucosa, neuroendocrine carcinomas of the oral cavity is rare. Herein, we presen...
Small cell cancer (SCC) of the tonsil is a rare and aggressive cancer. There are only 10 cases of to...
Small cell neuroendocrine carcinoma rarely appears primarily in the head and neck and exhibits aggre...
Neuroendocrine tumors are very rare tumors that occur most commonly in the gastrointestinal tract. T...
Patients with head and neck cancer have a greater risk of developing second primary malignant neopla...
We report a case of small cell neuroendocrine carcinoma of laryngeal localization. The involvement o...
Sinonasal Neuroendocrine Carcinoma (SNEC) is a very rare malignancy which is difficult to differenti...
Primary neuroendocrine carcinomas of the breast are extremely rare. Neuroendocrine tumors mainly occ...
Neuroendocrine tumors (NETs) arise from neuroendocrine cells and are mostly observed in the gastroin...
Neuroendocrine tumors are the most common nonsquamous types of laryngeal neoplasms. They are classif...
Extra pulmonary small cell carcinomas are extremely rare, accounting for 0.1-0.4% of all malignancie...